New Key Statistics Module, Z-Score and F-Score
SZSE:300705 Key Ratios
Market Cap ¥ M | 12,216.23 |
Enterprise Value ¥ M | 11,893.31 |
P/E(ttm) | 23.67 |
PE Ratio without NRI | 23.40 |
Forward PE Ratio | 17.64 |
Price/Book | 5.07 |
Price/Sales | 4.06 |
Price/Free Cash Flow | 51.45 |
Price/Owner Earnings | 43.08 |
Payout Ratio % | 0.30 |
Revenue (TTM) ¥ M | 2,945.00 |
EPS (TTM) ¥ | 1.04 |
Beneish M-Score | -2.29 |
10-y EBITDA Growth Rate % | 15.70 |
5-y EBITDA Growth Rate % | 41.30 |
y-y EBITDA Growth Rate % | 28.20 |
EV-to-EBIT | 21.05 |
EV-to-EBITDA | 21.05 |
PEG | 0.57 |
Shares Outstanding M | 494.38 |
Net Margin (%) | 17.25 |
Operating Margin % | 19.26 |
Pre-tax Margin (%) | 18.45 |
Quick Ratio | 3.35 |
Current Ratio | 4.23 |
ROA % (ttm) | 16.78 |
ROE % (ttm) | 24.08 |
ROIC % (ttm) | 25.58 |
Dividend Yield % | 1.30 |
Altman Z-Score | 11.00 |
SZSE:300705 Number of Guru Trades
SZSE:300705 Volume of Guru Trades
Gurus Latest Trades with SZSE:300705
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300705 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hunan Jiudian Pharmaceutical Co Ltd Insider Transactions
No Available Data